Our preclinical drug development offerings feature rigorous attention to your needs, including data integrity, scientific excellence, and a strong focus on animal welfare. Our preclinical services and clinical services work hand in hand to ensure a rapid and smooth transition from safety testing to first-in-human trials. Learn more about our preclinical solutions: https://www.altasciences.com/preclinical-research-services Contact us: https://www.altasciences.com/contact-us#inquiry About Altasciences: With over 30 years of experience conducting safety assessment, Altasciences offers a full range of in vivo GLP and non-GLP preclinical studies in multiple species to thoroughly assess the safety profile of your molecules. Working as an extension of your team, our scientists and technicians help you expedite your research goals, ensuring that your preclinical drug development program provides quality data for key decision making. Our solutions include IND-enabling and NDA-enabling toxicology, safety pharmacology, and laboratory services that meet global regulatory requirements, for both small and large molecules.

Step Inside Altasciences’ Bioanalytical Facility in Seattle, Washington
205 views

A Day In the Life of A Clinical Trial Participant
64 views

TIDES 2026—Hybridization LC-MS/MS: A Selective Solution for PMO and PPMO Bioanalysis
9 views

Accelerate Your Data With Our Co-located Clinic and Lab │Altasciences
11 views

Kansas Clinical Facility - Mini Virtual Tour
17 views

Webinar—Skin in the Game? Get Safety Right: Nonclinical Study Requirements for Dermal Therapies
6 views